Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT LIABILITIES (Details)

v3.24.2.u1
SELECTED FINANCIAL STATEMENT LIABILITIES (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Accounts payable:    
Clinical and regulatory expenses $ 670 $ 696
Professional fees 861 721
Selling expenses 1,807 1,498
Manufacturing costs 891 914
Non-employee director compensation 839 766
Other vendors 1,497 1,292
Total accounts payable 6,565 5,887
Accrued interest payable, related parties 587 542
Accrued interest payable 2,516 3,122
Accrued expenses:    
Payroll expenses 1,251 1,270
Government rebates and other rebates 7,181 5,881
Due to customers   844
Other accrued expenses 87 179
Total accrued expenses 8,519 8,174
Total accounts payable and accrued expenses $ 18,187 $ 17,725